In A549 lung cancer cells, CXCL12-CXCR4 promoted anti-apoptotic activity by activating JAK2/STAT3 pathway, greatly reducing the efficacy of chemotherapeutic drugs (such as cisplatin) 108. This evidence concerns the gene CXCR4 and lung carcinoma.